Device Trial Radar · NCT03430245
VelaShape III & UltraShape Power for Thigh Circumference Reduction
Last checked: Nov 20, 2026Latest source record: Jan 9, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
16
Actual
Start
Feb 19, 2018
Primary completion
May 30, 2019
Study completion Jul 3, 2019
Sponsor
- Lead sponsor
- Syneron MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 12, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Prospective, one-arm, baseline-controlled pilot study for the evaluation of the VelaShape III combined with UltraShape Power treatment for non-invasive circumference reduction to the thighs.
Conditions
- Circumference Reduction
Interventions
VelaShape IIIDevice
The VelaShape III device combines controlled infrared (IR) light and conducted bipolar radiofrequency (RF) energies with vacuum.
UltraShape PowerDevice
The UltraShape Power device uses focused ultrasound energy for lipolysis (breakdown of fat) via a non-thermal mechanism of action.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Circumference Change in the Thighs at the 12-week Follow-up Compared to Baseline MeasurementsTime frame: At 12 weeks after the third treatment (week 16) for each subject
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Skin Laser & Surgery Specialist of NY/NJ
Hackensack, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.